Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
31.21
+0.59 (1.93%)
Sep 4, 2025, 2:04 PM - Market open
Veracyte Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$39.89
Upside
+27.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $49 → $42 | Strong Buy | Maintains | $49 → $42 | +34.57% | May 8, 2025 |
| Needham | Needham | Strong Buy Maintains $51 → $41 | Strong Buy | Maintains | $51 → $41 | +31.37% | May 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $37 | Strong Buy | Maintains | $45 → $37 | +18.55% | Apr 9, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $45 | Buy | Reiterates | $45 | +44.18% | Mar 26, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +44.18% | Mar 20, 2025 |
| UBS | UBS | Strong Buy Maintains $46 → $49 | Strong Buy | Maintains | $46 → $49 | +57.00% | Feb 25, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +44.18% | Feb 25, 2025 |
| Needham | Needham | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +63.41% | Feb 25, 2025 |
| Needham | Needham | Strong Buy Maintains $44 → $51 | Strong Buy | Maintains | $44 → $51 | +63.41% | Jan 29, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $38 → $37 | Strong Buy → Hold | Downgrades | $38 → $37 | +18.55% | Dec 5, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $26 → $28 | Sell | Maintains | $26 → $28 | -10.29% | Nov 18, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $40 → $44 | Buy | Maintains | $40 → $44 | +40.98% | Nov 8, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $34 → $38 | Strong Buy | Maintains | $34 → $38 | +21.76% | Nov 7, 2024 |
| UBS | UBS | Strong Buy Maintains $43 → $46 | Strong Buy | Maintains | $43 → $46 | +47.39% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Maintains $37 → $44 | Strong Buy | Maintains | $37 → $44 | +40.98% | Nov 7, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +28.16% | Oct 17, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.